Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 12795 [2025-04533]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 52 / Wednesday, March 19, 2025 / Notices
12 p.m.–3:05 p.m.—MRSEC
Presentations (Open)
3:05 p.m.–3:50 p.m.—Working Lunch
(Closed)
3:50 p.m.–5:05 p.m.—Poster Session
(Open)
5:05 p.m.–5:50 p.m.—Executive
Sessions (Closed)
5:50 p.m.–6:15 p.m.—Debriefing (Open)
Reason for Closing: The program
being reviewed includes information of
a proprietary or confidential nature,
including technical information;
financial data, such as salaries, and
personal information concerning
individuals associated with the
program. These matters are exempt
under 5 U.S.C. 552b(c), (4) and (6) of the
Government in the Sunshine Act.
Dated: March 14, 2025.
Crystal Robinson,
Committee Management Officer.
[FR Doc. 2025–04537 Filed 3–18–25; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on April 7–8, 2025. A sample of agenda
items to be discussed include: a review
of recent medical events, evaluation of
recent Y–90 microsphere medical events
to identify potential cause of sudden
increase in reported events involving
unexpected GI deposition,
recommendations to the NRC on
knowledge topics encompassing the
safety related characteristics of emerging
medical technologies, recommendations
regarding development of process
checklists to minimize medical events,
Date
lotter on DSK11XQN23PROD with NOTICES1
Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1Y2FiNWUtYWNlYS00ZWYyLWIwZmIt
MmQxN2FhMjI4ZTcy%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a0655def4c64f52e%22%2c%22Oid%22%3a%229bbb685c-1b6d-4b62-94b5-49950ed15dbc%22%7d
Meeting ID: 215 307 484 116 Passcode: Df3Gn2QZ.
Call in number (audio only): +301–576–2978, Silver Spring.
Phone Conference ID: 312 941 521#.
Public Participation: The meeting will
be held in-person and as a webinar
using Microsoft Teams. Any member of
the public who wishes to participate in
the meeting in person, via Microsoft
Teams, or via phone should contact Ms.
A. Marra using the information below.
Members of the public should also
monitor the NRC’s Public Meeting
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates.
Contact Information: Ms. A. Marra,
email: Alessandra.Marra@nrc.gov,
telephone: 301–415–2509.
Conduct Of The Meeting:
The ACMUI Chair, Hossein Jadvar,
M.D., Ph.D. will preside over the
meeting. Dr. Jadvar will conduct the
meeting in a manner that will facilitate
the orderly conduct of business. The
following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. A. Marra using
the contact information listed above. All
submittals must be received by the close
of business on April 1, 2025, and must
only pertain to the topics on the agenda.
2. Questions and comments from
members of the public will be permitted
18:11 Mar 18, 2025
and NRC’s medical radiation safety team
updates including work to enhance
licensing and oversight efficiency in
accordance with the Advanced Act. The
agenda is subject to change. The current
agenda and any updates will be
available on the ACMUI’s Meetings and
Related Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/
or by emailing Ms. A. Marra at the
contact information below.
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Date and Time for Open Sessions:
April 7, 2025, from 9:00 a.m. to 4:00
p.m. and April 8, 2025, from 10:00 a.m.
to 12:00 p.m. Eastern Standard Time.
Address for Public Meeting: U.S.
Nuclear Regulatory Commission, One
White Flint North Building
(Commissioner’s Hearing Room, O1–
F16/O1–G16), 11555 Rockville Pike,
Rockville, Maryland, 20852.
Webinar information (microsoft teams)
April 7, 2025 .................................
VerDate Sep<11>2014
12795
Jkt 265001
during the meeting, at the discretion of
the ACMUI Chair.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2024.html on or about May 23, 2025.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. A. Marra of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. 1001 et seq.); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations, Part 7
Dated at Rockville, Maryland this 14th day
of March, 2025.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2025–04533 Filed 3–18–25; 8:45 am]
BILLING CODE 7590–01–P
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[NRC–2025–0010]
State of Connecticut: NRC Staff
Assessment of a Proposed Agreement
Between the Nuclear Regulatory
Commission and the State of
Connecticut
Nuclear Regulatory
Commission.
ACTION: Proposed state agreement;
request for comment.
AGENCY:
As required by Section 274e.
of the Atomic Energy Act of 1954, as
amended (AEA), the U.S. Nuclear
Regulatory Commission (NRC or
Commission) is publishing the proposed
Agreement for public comment
(Appendix A). The NRC is also
publishing the summary of a draft
assessment by the NRC staff of the State
of Connecticut’s regulatory program.
Comments are requested on the
proposed Agreement and its effect on
public health and safety. Comments are
also requested on the draft staff
assessment, the adequacy of the State of
Connecticut’s program, and the
SUMMARY:
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 90, Number 52 (Wednesday, March 19, 2025)]
[Notices]
[Page 12795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-04533]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
April 7-8, 2025. A sample of agenda items to be discussed include: a
review of recent medical events, evaluation of recent Y-90 microsphere
medical events to identify potential cause of sudden increase in
reported events involving unexpected GI deposition, recommendations to
the NRC on knowledge topics encompassing the safety related
characteristics of emerging medical technologies, recommendations
regarding development of process checklists to minimize medical events,
and NRC's medical radiation safety team updates including work to
enhance licensing and oversight efficiency in accordance with the
Advanced Act. The agenda is subject to change. The current agenda and
any updates will be available on the ACMUI's Meetings and Related
Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/ or by emailing Ms. A. Marra at the contact
information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: April 7, 2025, from 9:00 a.m. to
4:00 p.m. and April 8, 2025, from 10:00 a.m. to 12:00 p.m. Eastern
Standard Time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One
White Flint North Building (Commissioner's Hearing Room, O1-F16/O1-
G16), 11555 Rockville Pike, Rockville, Maryland, 20852.
----------------------------------------------------------------------------------------------------------------
Date Webinar information (microsoft teams)
----------------------------------------------------------------------------------------------------------------
April 7, 2025............................... Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1Y2FiNWUtYWNlYS00ZWYyLWIwZmItMmQxN2FhMjI4ZTcy%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%229bbb685c-1b6d-4b62-94b5-49950ed15dbc%22%7d
Meeting ID: 215 307 484 116 Passcode: Df3Gn2QZ.
Call in number (audio only): +301-576-2978, Silver Spring.
Phone Conference ID: 312 941 521#.
----------------------------------------------------------------------------------------------------------------
Public Participation: The meeting will be held in-person and as a
webinar using Microsoft Teams. Any member of the public who wishes to
participate in the meeting in person, via Microsoft Teams, or via phone
should contact Ms. A. Marra using the information below. Members of the
public should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
Contact Information: Ms. A. Marra, email: [email protected],
telephone: 301-415-2509.
Conduct Of The Meeting:
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D. will preside over the
meeting. Dr. Jadvar will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. A. Marra using the contact information listed
above. All submittals must be received by the close of business on
April 1, 2025, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 23, 2025.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. A. Marra of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. 1001 et seq.); and the Commission's regulations
in Title 10 of the Code of Federal Regulations, Part 7
Dated at Rockville, Maryland this 14th day of March, 2025.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2025-04533 Filed 3-18-25; 8:45 am]
BILLING CODE 7590-01-P
